Adam Burgoyne, MD, PhD

Associate Clinical Professor
University of California, San Diego, United States

Presentation(s):

• Rates of Complete Pathologic Necrosis Among Locoregional Therapy Modalities for 3-5 cm Hepatocellular Carcinomas Undergoing Transplantation

  Sunday, March 30, 2025
  4:03 PM – 4:12 PM CT

• Circulating tumor DNA (ctDNA) to predict response to intra-arterial therapy in patients with hepatocellular carcinoma: a pilot, prospective clinical trial

  Tuesday, April 1, 2025
  3:27 PM – 3:36 PM CT